Lei Chen

Title: Innovations by Lei Chen in Sequencing Data Correction

Introduction

Lei Chen is an accomplished inventor based in Tarrytown, NY (US). He has made significant contributions to the field of genetics and bioinformatics, particularly in the area of sequencing data analysis. His innovative work focuses on improving the accuracy of genotype identification for high repeat genes.

Latest Patents

Lei Chen holds a patent titled "Systems and methods for correcting for noise and systemic variations in sequencing data." This patent outlines a comprehensive approach to enhance the accuracy of genotype determination. The process begins with identifying repeat structures in sequencing reads and removing those with abnormal structures to create a refined dataset. Subsequent filtering excludes sequences with structural artifacts, leading to a more accurate representation of the data. The final output includes a consensus sequence for each allele, which is then translated into corresponding amino-acid sequences to determine protein-altering variant status. This innovative method has the potential to significantly advance genetic research and applications.

Career Highlights

Lei Chen is currently employed at Regeneron Pharmaceuticals, Inc., where he continues to develop and refine his innovative techniques. His work at Regeneron has positioned him as a key contributor to advancements in genetic research and therapeutic development.

Collaborations

Lei collaborates with notable colleagues, including Charles Paulding and Amy Damask, who contribute to the dynamic research environment at Regeneron Pharmaceuticals.

Conclusion

In summary, Lei Chen's innovative contributions to sequencing data correction exemplify the intersection of technology and genetics. His work not only enhances the accuracy of genetic analysis but also paves the way for future advancements in the field.